ISOLS 2026: Vienna brings together the international orthopaedic oncology community

Vienna, September 24, 2026 — The 23rd General Meeting of the International Society of Limb Salvage (ISOLS) is currently bringing together around 1,000 participants at VIECON – Vienna Congress & Convention Center. Specialists from countries across Europe, Asia, the Americas, Australia and other regions are contributing to a truly international scientific exchange. 

Running from September 23–26, the four-day meeting offers an exceptionally dense program covering virtually every major aspect of musculoskeletal oncology and limb salvage. Among the topics are megaprostheses and long-term outcomes, biological reconstruction, sarcoma surgery, imaging, infections, paediatric oncology, pelvic reconstruction, metastases, novel systemic therapies, artificial intelligence, robotics, mixed reality, 3D-printed solutions, precision medicine and patient-reported outcomes. (isols2026.org)

The meeting also reflects the remarkable history of ISOLS. The Society traces its origins to the first international workshop on tumor prostheses and bone and joint reconstruction held at Mayo Clinic in Rochester in 1981. Vienna itself played an important role early in this history: the second workshop was held here in 1983. The organization subsequently developed into an international professional society and has contributed to advances in limb reconstruction, functional assessment and limb-salvage techniques. 

For orthopaedics, the significance of ISOLS lies in its multidisciplinary approach: surgeons, oncologists, engineers, researchers and other specialists work together around one central goal — preserving the limb, function and quality of life of patients with musculoskeletal tumours. The 2026 program continues this tradition while looking toward new technologies and future models of care. The meeting has also been accredited for 17 European CME credits.

And there is perhaps no more fitting setting than Vienna — a city with a long medical tradition, where history, science and culture meet. For several days, Vienna has become a meeting point for the international community shaping the future of orthopaedic oncology.